CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 65 enrolled
Drug / intervention
G0041(75/100mg) +1 moredrug
Likely dose
G0041(75/100mg)from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01526122
NCT01526122Phase 1Completed
CompareCT.gov

A PhaseⅠ Study to Compare the Pharmacokinetic Characteristics and Safety After Oral Administration of G0041(75/100mg) With Those of Clopidogrel 75mg & Aspirin 100mg Coadministration in Healthy Male Volunteers

Dong-A ST Co., Ltd.·interventional·Posted Feb 3, 2012·Updated Oct 1, 2014

In Brief

A Phase 1 clinical trial evaluating G0041(75/100mg) and Clopidogrel & Aspirin for Atherosclerosis. Completed, enrolled 65 participants.

Detailed Summary

The purpose of this study is to compare characteristics and safety after oral administration of G0041(75/100mg) 2 tablets with those of Clopidogrel 75mg 2 tablets \& Aspirin 100mg 2 capsules coadministration in healthy male volunteers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtherosclerosis
Countries--
Collaborators--

Timeline

Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedFeb 3, 2012
Enrollment StartSep 1, 2011
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 14.4 years ago

Interventions

G0041(75/100mg)drug

G0041(75/100mg) 2 capsules(Clopidogrel 75mg \& Aspirin 100mg in 1 capsule), PO

Clopidogrel & Aspirindrug

Clopidogrel 75mg 2 tablets \& Aspirin 100mg 2 capsules, PO